IP Verse

Inserm (institut National De La Santé Et De La Recherche Médicale) opposition analysis

COMPANY ANALYSIS

Latest patents of Inserm (institut National De La Santé Et De La Recherche Médicale) opposed by its competitors

Patent:
EP3911354
Grant Date:
Apr 3, 2024
Title:
Aav-Mediated Gene Therapy Restoring The Otoferlin Gene
Oppositions:
4
Patent:
EP3066203
Grant Date:
Nov 8, 2023
Title:
New Alzheimer'S Disease Animal Model
Oppositions:
1
Patent:
EP3995507
Grant Date:
Oct 4, 2023
Title:
Il-15 And Il-15Ralpha Sushi Domain Based On Modulokines
Oppositions:
1
Patent:
EP3768304
Grant Date:
Oct 12, 2022
Title:
Compositions And Methods For Increasing Or Enhancing Transduction Of Gene Therapy Vectors And For Removing Or Reducing Immunoglobulins
Oppositions:
6
Patent:
EP3059307
Grant Date:
May 4, 2022
Title:
Use Of A Laminin For Differentiating Pluripotent Cells Into Hepatocyte Lineage Cells
Oppositions:
1
Patent:
EP3320101
Grant Date:
Aug 11, 2021
Title:
Methods And Pharmaceutical Compositions For Expressing A Polynucleotide Of Interest In The Peripheral Nervous System Of A Subject
Oppositions:
1
Patent:
EP3443979
Grant Date:
May 27, 2020
Title:
Il-2 Dosage Regimen For Treating Systemic Lupus Erythematosus
Oppositions:
1
Patent:
EP3019610
Grant Date:
May 6, 2020
Title:
Methods For Performing Antisense Oligonucleotide-Mediated Exon Skipping In The Retina Of A Subject In Need Thereof
Oppositions:
1
Patent:
EP2683395
Grant Date:
Aug 1, 2018
Title:
Use Of Low Dose Il-2 For Treating Autoimmune - Related Or Inflammatory Disorders
Oppositions:
1
Patent:
EP2855678
Grant Date:
Aug 23, 2017
Title:
Methods For Selecting Binders By Phage Display And Masked Selection
Oppositions:
1

Competitors of Inserm (institut National De La Santé Et De La Recherche Médicale)

STRAWMAN LIMITED

MICHALSKI HUTTERMANN & PARTNER PATENTANWALTE MBB

SANOFI

Want to track Inserm (institut National De La Santé Et De La Recherche Médicale)?

Feel free to send us a message here and we will get back to you